Study on the Expression of ATlreceptor,VEGF,MVD and Their Correlations in Breast Cancer
Sui Guang
Abstract
Sui Guang
Abstract
Objective:To study the expression of ATlreceptor,VEGF,CD34 and their correlation in breast cancer. Methods:The expression of ATlreceptor,VFGF,CD34 in paraffin-embedded breast cancer for 102 cases was detected by im- munohistochemical technique(SP).Results:The positive expression rate of ATlreceptor was 48% in breast cancer.There were 61.8% ATlreceptor with lymphnode metastasis while 31.9% without lymphnode metastasis in breast cancer(P<0.05).The positive expression rate of VEGF was 40.2% in breast cancer,44.4% with lymphnode metastasis and 23.5% without it(P<0.01).In the ATlreceptor group of negative expression,the positive expression rate of VEGF was 11.3%(6/53),while in the ATlreceptor group of posidve expression,it was 71.4%(35/49),with an obvious difference(P<0.05).The MVD was 17.349±5.67 in the breast cancer of negative expression of AT1 receptor,while it was 20.37±7.30 in the breast cancer of positive expression of AT1 receptor.And it was 17.14±5.78 in the breast cancer of negadve expression of VEGF while 21.27±7.14 in the breast cancer of positive expression of VEGF.The difference was remarkable(P<0.05).Conclusion:The positive expression rate of ATlreceptor and VEGF was 48% and 40.2%,respectivdy.Neither of the expression of ATlreceptor and VEGF was related with age,tumor size,ER or PR,but both have a posidve correlation with lymphnode metastasis.The ATlreceptor also has a positive correlation with VEGF.In the breast cancer,MVD,AT1 receptor and VEGF,they all have a positive correladon with each other as well.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the expression of ATlreceptor,VEGF,CD34 and their correlation in breast cancer. Methods:The expression of ATlreceptor,VFGF,CD34 in paraffin-embedded breast cancer for 102 cases was detected by im- munohistochemical technique(SP).Results:The positive expression rate of ATlreceptor was 48% in breast cancer.There were 61.8% ATlreceptor with lymphnode metastasis while 31.9% without lymphnode metastasis in breast cancer(P<0.05).The positive expression rate of VEGF was 40.2% in breast cancer,44.4% with lymphnode metastasis and 23.5% without it(P<0.01).In the ATlreceptor group of negative expression,the positive expression rate of VEGF was 11.3%(6/53),while in the ATlreceptor group of posidve expression,it was 71.4%(35/49),with an obvious difference(P<0.05).The MVD was 17.349±5.67 in the breast cancer of negative expression of AT1 receptor,while it was 20.37±7.30 in the breast cancer of positive expression of AT1 receptor.And it was 17.14±5.78 in the breast cancer of negadve expression of VEGF while 21.27±7.14 in the breast cancer of positive expression of VEGF.The difference was remarkable(P<0.05).Conclusion:The positive expression rate of ATlreceptor and VEGF was 48% and 40.2%,respectivdy.Neither of the expression of ATlreceptor and VEGF was related with age,tumor size,ER or PR,but both have a posidve correlation with lymphnode metastasis.The ATlreceptor also has a positive correlation with VEGF.In the breast cancer,MVD,AT1 receptor and VEGF,they all have a positive correladon with each other as well.
Key concepts: Breast cancer, Medicine, Metastasis, Cancer, VEGF receptors, Internal medicine, Oncology, Correlation